<?xml version="1.0" encoding="UTF-8"?>
<p id="p0240">Another promising development is the use of rapid tests for biomarkers of bacterial or viral infection (C-reactive protein, procalcitonin, tumor necrosis factor-related apoptosis-inducing ligand [TRAIL], interferon gamma-inducible protein 10 [IP-10], Myxovirus resistance A [MxA]) to rule out the more severe bacterial etiology and prevent inappropriate antibiotic usage.</p>
